Annual Cash & Cash Equivalents:
$114.09M+$64.79M(+131.40%)Summary
- As of today, MLYS annual cash & cash equivalents is $114.09 million, with the most recent change of +$64.79 million (+131.40%) on December 31, 2024.
- During the last 3 years, MLYS annual cash & cash equivalents has risen by +$103.48 million (+975.11%).
- MLYS annual cash & cash equivalents is now at all-time high.
Performance
MLYS Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$324.92M-$18.11M(-5.28%)Summary
- As of today, MLYS quarterly cash & cash equivalents is $324.92 million, with the most recent change of -$18.11 million (-5.28%) on June 30, 2025.
- Over the past year, MLYS quarterly cash & cash equivalents has increased by +$13.80 million (+4.44%).
- MLYS quarterly cash & cash equivalents is now -5.28% below its all-time high of $343.03 million, reached on March 31, 2025.
Performance
MLYS Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MLYS Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +131.4% | +4.4% |
| 3Y3 Years | +975.1% | - |
| 5Y5 Years | +7997.3% | +2947.4% |
MLYS Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +975.1% | -5.3% | +563.7% |
| 5Y | 5-Year | at high | +7997.3% | -5.3% | +2947.4% |
| All-Time | All-Time | at high | +7997.3% | -5.3% | +2947.4% |
MLYS Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $324.92M(-5.3%) |
| Mar 2025 | - | $343.03M(+73.1%) |
| Dec 2024 | $114.09M(+131.4%) | $198.19M(-24.8%) |
| Sep 2024 | - | $263.60M(-15.3%) |
| Jun 2024 | - | $311.12M(-8.1%) |
| Mar 2024 | - | $338.56M(+43.1%) |
| Dec 2023 | $49.30M | $236.57M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $253.76M(-2.8%) |
| Jun 2023 | - | $261.10M(-3.5%) |
| Mar 2023 | - | $270.64M(+145.8%) |
| Dec 2022 | $87.70M(+726.4%) | $110.11M(+124.9%) |
| Sep 2022 | - | $48.95M(+359.2%) |
| Dec 2021 | $10.61M(+653.2%) | - |
| Dec 2021 | - | $10.66M |
| Dec 2020 | $1.41M | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Mineralys Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MLYS is $114.09M
What is the all-time high annual cash & cash equivalents for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual cash & cash equivalents is $114.09M
What is Mineralys Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MLYS annual cash & cash equivalents has changed by +$64.79M (+131.40%)
What is Mineralys Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MLYS is $324.92M
What is the all-time high quarterly cash & cash equivalents for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $343.03M
What is Mineralys Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MLYS quarterly cash & cash equivalents has changed by +$13.80M (+4.44%)